About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 623   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size


 
SYMPOSIUM - ONCOLOGY UPDATE
Year : 2010  |  Volume : 17  |  Issue : 3  |  Page : 207-209 Table of Contents     

Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma


1 Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
2 Interventional Neuroradiology, Departments of Radiology, Neurosurgery and Neurology, Weill Cornell Medical College, New York, NY, USA
3 Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
4 Department of Ophthalmology, Mt. Sinai School of Medicine, New York, NY, USA

Date of Web Publication15-Jul-2010

Correspondence Address:
Brian Marr
70 East 66th Street, New York, NY 10065
USA
Login to access the Email id

Source of Support: Grant from “The Fund for Ophthalmic Knowledge, Inc., Conflict of Interest: None


DOI: 10.4103/0974-9233.65492

Rights and Permissions
   Abstract 

Purpose and Design: To describe an unusual clinical finding seen in children undergoing intra-arterial chemotherapy for retinoblastoma.
Materials and Methods: A retrospective review of 69 eyes of 63 patients receiving intra-arterial chemotherapy over a 3-year period. Charts and photographs of 69 consecutive cases were reviewed, and data were collected on patients with clinical evidence of a hyperemic cutaneous periocular abnormality following the procedure.
Results: A blanching erythematous and edematous patch was noted in the periocular region in 16% (11 of 69) of the children who received intraarterial chemotherapy. The plaque extended into the region of the supertrochlear and medial marginal artery distribution on the ipsilateral side of the intra-arterial chemotherapy. All patches of erythema spontaneously resolved within 3 months following completion of the intra-arterial chemotherapy.
Conclusion: Periocular erythema and swelling is a self-limited clinical finding associated with intra-arterial chemotherapy in a small number of patients.

Keywords: Cancer, Eye, Intra-Arterial Chemotherapy, Melphalan, Retinoblastoma, Skin, Topotican


How to cite this article:
Marr B, Gobin PY, Dunkel IJ, Brodie SE, Abramson DH. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol 2010;17:207-9

How to cite this URL:
Marr B, Gobin PY, Dunkel IJ, Brodie SE, Abramson DH. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol [serial online] 2010 [cited 2019 Sep 19];17:207-9. Available from: http://www.meajo.org/text.asp?2010/17/3/207/65492


   Introduction Top


Treatment using super selective intra-arterial chemotherapy has been used successfully to treat eyes with bilateral and unilateral retinoblastoma. [1],[2] Results on electroretinographic findings and efficacy have been described. [1],[3] Currently, swelling is the only adverse periocular effect reported in the English literature following such treatments. [1] We describe an unusual clinical finding seen following intra-arterial chemotherapy.


   Materials and Methods Top


After an institutional review board approval, a retrospective review of 69 eyes receiving intra-arterial chemotherapy was performed on 63 consecutive patients beginning in May of 2006. The same physician preformed all procedures using the same technique (YPG) [1] [Figure 1]. Charts and photographs were reviewed for patients having an associated hyperemic cutaneous periocular abnormality following chemosurgery; demographic and procedure data were collected.


   Results Top


Of the 69 consecutive eyes of 63 children, 11 (16%) were found to have a hyperemic cutaneous periocular abnormality found in the skin. This condition occurred twice in one patient of the 12 occurences in 196 (6%) consecutive procedures. The redness consisted of a geographic erythematous plaque that blanched with pressure [Figure 2]a,b. The extent of the lesions corresponded to the distribution of the supratrochlear and medial palpebral arteries. The hyperemic cutaneous periocular abnormality was not present immediately after the infusion and was noted to appear within the first 24-48 hrs following the procedure, then faded slowly. No child had bilateral findings during tandem treatments. No intervention was given to the patients, and they had no symptoms of pain or pruritus. As it resolved spontaneously, no biopsy was recommended. The age of affected patients ranged from 3 to 120 months. All children's eyes with the hyperemic cutaneous periocular abnormality received melphalan in doses ranging from 3 to 7.5 mg. Topotecan was used in two patients, and the dose ranged from 0.4 to 3.0 mg [Table 1]. It was noted during the intra-arterial infusion that in 4 (36%) out of the 11 patients, injection was made with the catheter in "wedge flow." Wedge flow is characterized by a slowing of contrast distal to the catheter tip angiographically that occurs when the catheter tip partially obstructs the ophthalmic artery limiting normal arterial flow. This is in contrast to the 3/58 (5%) eyes that were noted to be in wedge flow that did not develop the cutaneous findings, two of the three eyes without cutaneous findings had mild conjunctival redness and swelling. No other complications were noted in children with the hyperemic cutaneous periocular abnormality except for eyelash loss. Eight out of the 11 (73%) eyes with the hyperemic cutaneous periocular abnormality also had associated eyelash loss on the medial third of the upper eyelid. Eyelash loss was always associated with skin changes and was not noted alone in the 58 eyes without skin erythema. The hyperemic cutaneous periocular abnormality and eyelash loss spontaneously resolved within 3 months following completion of the intra-arterial chemotherapy [Figure 2]c.


   Discussion Top


Reversible cutaneous hyperemia following intra-arterial chemotherapy has been described with nonophthalmic cancers. In treatment of advanced head and neck cancer with intra-arterial chemotherapy using vincristine, bleomycin, and methotrexate or cisplatin and bleomycin, local cutaneous reactions were described in 8% of cases of which nearly all spontaneously resolved. [4] Melphalan itself has been associated with reticulate scleroderma and ulceration after isolated limb perfusion (ILP) for treatment of melanoma. [5] In one study, erythema and localized swelling were described in 80% of 181 patients who underwent melphalan ILP for limb melanoma. [6]

Sixteen percent of our patients had a distinctive hyperemic cutaneous periocular abnormality following intra-arterial chemotherapy Intensity, size, and duration of the hyperemic cutaneous periocular abnormality varied among the 11 patients. Age, timing, type of chemotherapy used, and dose varied within the group. With regards to dose, patients with a reaction tended to be in the higher dose range for their age. During the procedure, four of 11 patients (36%) were in wedge flow. Wedge flow results in a less-diluted infusion of drug secondary to the partial obstruction of the ophthalmic artery by the catheter tip during the infusion. It is possible that this may contribute to the cutaneous changes observed in our patients. Seventy-three percentage of patients with the hyperemic cutaneous periocular abnormality also had ciliary madarosis. The resolution of the hyperemic cutaneous periocular abnormality preceded the re-growth of cilia in all cases. This side effect occurs in a small percentage of patients and is self-limited. It is unknown if the infusion technique, dose, or vascular anatomy contribute to its frequency.


   Acknowledgements Top


This study was supported in part by a grant from "The Fund for Ophthalmic Knowledge, Inc." This study was reviewed by and is in compliance with the Institutional Review Board of Memorial Sloan-Kettering Cancer Center.

 
   References Top

1.Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intra-arterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115:1398-404.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: Tandem therapy. Arch Ophthalmol 2010;128:370-2.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 2009;119:13-22.   Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Claudio F, Cacace F, Comella G, Coucourde F, Claudio L, Bevilacqua AM, et al. Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer. Cancer 1990;65:1465-71.  Back to cited text no. 4  [PUBMED]    
5.Landau M, Brenner S, Gat A, Klausner JM, Gutman M. Reticulate scleroderma after isolated limb perfusion with melphalan. J Am Acad Dermatol 1998;39:1011-2.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Vrouenraets BC, Kroon BB, Klaase JM, Nieweg OE, van Slooten GW, van Dongen JA. Severe acute regional toxicity after normothermic or "mild" hyperthermic isolated limb perfusion with melphalan for melanoma. Melanoma Res 1995;5:425-31.  Back to cited text no. 6  [PUBMED]    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1]


This article has been cited by
1 Complications of Intra-Arterial Chemotherapy for Retinoblastoma
Jose Efren Gonzalez Monroy,Darren B. Orbach,Deborah VanderVeen
Seminars in Ophthalmology. 2014; 29(5-6): 429
[Pubmed] | [DOI]
2 Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments
Carlo Venturi,Sandra Bracco,Alfonso Cerase,Samuele Cioni,Paolo Galluzzi,Paola Gennari,Ignazio M. Vallone,Rebecca Tinturini,Cesare Vittori,Sonia De Francesco,Mauro Caini,Alfonso D’Ambrosio,Paolo Toti,Alessandra Renieri,Theodora Hadjistilianou
Acta Ophthalmologica. 2013; 91(4): 335
[Pubmed] | [DOI]
3 Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment
Sotiria Palioura,Y. Pierre Gobin,Scott E. Brodie,Brian P. Marr,Ira J. Dunkel,David H. Abramson
Pediatric Blood & Cancer. 2012; 59(5): 859
[Pubmed] | [DOI]
4 Letter to the Editor
Y. Pierre Gobin,Brian P. Marr,Ira J. Dunkel,David H. Abramson,Scott E. Brodie
Journal of Neurosurgery. 2012; 116(2): 470
[Pubmed] | [DOI]
5 Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization
M. A. Klufas,Y. P. Gobin,B. Marr,S. E. Brodie,I. J. Dunkel,D. H. Abramson
American Journal of Neuroradiology. 2012; 33(8): 1608
[Pubmed] | [DOI]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Materials and Me...
    Results
    Discussion
    Acknowledgements
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed4144    
    Printed211    
    Emailed1    
    PDF Downloaded209    
    Comments [Add]    
    Cited by others 5    

Recommend this journal